zum Inhalt

Peter LLEWELLYN-DAVIES Chief Executive Officer, APEIRON Biologics AG, Vienna

CV

  Education
  Business Studies, University of London
  Marketing, St. Galler Business School, St. Gallen
  Fellowship of the London Institute of Banking and Finance
1996-2003 Managing Director, Süd-Chemie AG, Munich
2003-2005 Executive Director, Müller Dairy UK Ltd.
2006-2012 Chief Financial Officer, Wilex AG, Munich
2012-2016 Chief Financial Officer and Chief Business Officer, Medigene AG, Munich
since 2006 Founder and Chief Executive Officer, Accellerate Partners, London and Munich
since 2016 Non-Executive Director and Chairman of Audit Committee, Shield Therapeutics PLC, London
since 2017 Member of the Supervisory Board and Chairman of Audit Committee, Sygnis AG, Heidelberg
since 2017 Chief Financial Officer and Chief Business Officer, APEIRON Biologics AG, Vienna
since 2018 Chief Executive Officer, APEIRON Biologics AG, Vienna